Materiały źródłowe

• #1 Atypical Ductal Hyperplasia: Breast, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/16242-atypical-ductal-hyperplasia

  Atypical ductal hyperplasia occurs when you have abnormal cells in the milk ducts of your breast. These cells have a higher-than-normal chance of becoming cancerous. A breast biopsy diagnoses it. Your provider may recommend additional mammograms if you have atypical ductal hyperplasia. […] Atypical ductal hyperplasia (ADH or atypia ductal hyperplasia) is when you have abnormal cells in the lining of the milk ducts in your breasts. […] If your breast biopsy shows atypical ductal hyperplasia, it doesn’t mean that you have cancer. The cells are a marker for increased breast cancer risk. Studies have shown that people with either type of atypical hyperplasia may be up to four times more likely to get breast cancer compared to those who don’t. […] There are sometimes no symptoms of ADH. It’s a condition your healthcare provider may find during an examination or breast cancer screening. Some people develop lumps, pain or irregular nipple discharge which can alert them that something is wrong with their breasts.

• #2 Hyperplasia and atypical hyperplasia | Breast Cancer Now

  https://breastcancernow.org/about-breast-cancer/breast-lumps-and-benign-not-cancer-breast-conditions/hyperplasia-and-atypical-hyperplasia

  Atypical hyperplasia (also called epithelial hyperplasia) happens when cells lining the ducts or lobules increase in number and develop an unusual pattern or shape. […] Atypical hyperplasia is also benign (not cancer). However, having atypical hyperplasia has been shown to increase the risk of breast cancer in some people. […] Hyperplasia and atypical hyperplasia do not usually cause any symptoms. Because of this, they’re usually found by chance when breast tissue that has been removed during a biopsy or breast surgery is examined under a microscope in the laboratory. […] If you have atypical hyperplasia, your risk of breast cancer is increased. Your treatment team will explain if and how you will be followed up. […] Go back to your GP if you notice any changes, no matter how soon they appear after your diagnosis of atypical hyperplasia.

• #3 Atypical hyperplasia of the breast | Altru Health System

  https://www.altru.org/health-library/conditions/atypical-hyperplasia-of-the-breast

  Atypical hyperplasia of the breast usually doesn’t cause any symptoms. […] Atypical hyperplasia of the breast is typically found during a breast biopsy. […] If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia. […] Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time. At 25 years after diagnosis, about 30% of women with atypical hyperplasia may have breast cancer.

• #4 Atypical hyperplasia of the breast | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/breast/what-is-breast-cancer/non-cancerous-conditions/atypical-hyperplasia

  Atypical hyperplasia of the breast does not cause any symptoms. It is usually found during screening mammography. […] Having atypical hyperplasia increases the risk for breast cancer. This risk is even higher in women who have a family history of breast cancer or who are diagnosed with atypical hyperplasia before they reach menopause. Breast cancer is more likely to start in the breast where atypical hyperplasia is found. The risk of developing breast cancer is greatest 10-15 years after atypical hyperplasia is diagnosed. The risk begins to go down after 15 years.

• #5

  https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=acf2776

  Atypical hyperplasia of the breast means that there are extra cells in the breast that are not normal. These cells may be in the milk ducts (atypical ductal hyperplasia). Or they may be in the lobes (atypical lobular hyperplasia). It is not cancer. But having it increases the risk of breast cancer. […] Usually there are no symptoms of atypical hyperplasia. The changes in breast tissue are too small to be felt.

• #6 Atypical Hyperplasia

  https://cbcn.ca/en/atypical-hyperplasia

  Po 5 latach od zdiagnozowania atypowej hiperplazji 7% kobiet zostanie zdiagnozowanych z rakiem piersi; 10 lat po diagnozie atypowej hiperplazji 13% kobiet zostanie zdiagnozowanych z rakiem piersi; a 25 lat po diagnozie atypowej hiperplazji 30% kobiet rozwinie raka piersi. […] Nie ma zauważalnych oznak ani objawów atypowej hiperplazji; może wystąpić ból piersi, ale jest to bardzo rzadkie. Nie można jej również wykryć podczas badania piersi ani obrazowania piersi. […] Po zdiagnozowaniu atypowej hiperplazji może być wykonany test E-kadheryny, aby określić, czy masz ADH czy ALH.

• #7

  https://www.cancervic.org.au/cancer-information/screening/breasts-health/atypical-ductal-hyperplasia

  If you’ve been diagnosed with ADH, you’ll need expert advice on the treatment and follow-up that’s best for you. […] In most women ADH is harmless and won’t cause any problems in the future. However, in a few women with ADH, breast cancer can occur at a later date in the same breast or in the other one. Learning about this risk can raise anxiety in women newly diagnosed with ADH, but the risk is small. With regular follow-up, any breast cancer that does develop is likely to be found early. […] ADH doesn’t normally cause changes that can be felt. In this sense it is an 'accidental’ finding.

• #8 Atypical hyperlasia of the breast | The London Clinic

  https://www.thelondonclinic.co.uk/services/conditions/atypical-hyperplasia-breast

  Atypical hyperplasia of the breast is a condition in which breast tissue enlarges and overgrows. In itself, atypical hyperplasia is benign but if you have it, you may have a slightly increased risk of developing breast cancer in the future. […] If you have atypical hyperplasia you dont generally get any symptoms and the areas of excess breast tissue may not be large enough to notice. […] The condition isnt painful and may only be discovered by chance or as part of routine breast screening. […] It is important to remember that, while atypical hyperplasia is linked with a slightly increased risk of developing breast cancer in the future, this does not mean that it will happen to everyone with atypical hyperplasia.

• #9 Atypical Ductal Hyperplasia: Symptoms and Treatment

  https://www.verywellhealth.com/atypical-ductal-hyperplasia-of-the-breast-430683

  Atypical ductal hyperplasia usually doesn’t cause any notable symptoms. It is usually a subsequent finding of a biopsy done to evaluate a benign breast lump or findings on mammogram imaging. Atypical ductal hyperplasia may cause breast pain, though this is rare. […] Since ADH can go undetected until testing for a potential breast cancer diagnosis is done, it’s important that you are aware of the signs and symptoms of breast cancer and see your healthcare provider if you notice any changes in your breast that concern you. […] If the condition is not properly managed, it will continue to progress and eventually become breast cancer.

• #10 Atypical Hyperplasia

  https://cbcn.ca/en/atypical-hyperplasia

  Po 5 latach od zdiagnozowania atypowej hiperplazji 7% kobiet zostanie zdiagnozowanych z rakiem piersi; 10 lat po diagnozie atypowej hiperplazji 13% kobiet zostanie zdiagnozowanych z rakiem piersi; a 25 lat po diagnozie atypowej hiperplazji 30% kobiet rozwinie raka piersi. […] Nie ma zauważalnych oznak ani objawów atypowej hiperplazji; może wystąpić ból piersi, ale jest to bardzo rzadkie. Nie można jej również wykryć podczas badania piersi ani obrazowania piersi. […] Po zdiagnozowaniu atypowej hiperplazji może być wykonany test E-kadheryny, aby określić, czy masz ADH czy ALH.

• #11 Atypical Ductal Hyperplasia: Breast, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/16242-atypical-ductal-hyperplasia

  Atypical ductal hyperplasia occurs when you have abnormal cells in the milk ducts of your breast. These cells have a higher-than-normal chance of becoming cancerous. A breast biopsy diagnoses it. Your provider may recommend additional mammograms if you have atypical ductal hyperplasia. […] Atypical ductal hyperplasia (ADH or atypia ductal hyperplasia) is when you have abnormal cells in the lining of the milk ducts in your breasts. […] If your breast biopsy shows atypical ductal hyperplasia, it doesn’t mean that you have cancer. The cells are a marker for increased breast cancer risk. Studies have shown that people with either type of atypical hyperplasia may be up to four times more likely to get breast cancer compared to those who don’t. […] There are sometimes no symptoms of ADH. It’s a condition your healthcare provider may find during an examination or breast cancer screening. Some people develop lumps, pain or irregular nipple discharge which can alert them that something is wrong with their breasts.

• #12 Atypical Hyperplasia of Breast | Symptoms, Causes & Treatment

  https://fitwellhub.pk/atypical-hyperplasia/

  Atypical hyperplasia may be symptomless. It occurs during regular breast imaging, but some people may feel they have this if the following symptoms are noted: […] In some cases, the condition may present as a palpable tumor in the breast. It may be identified during a self-exam or by a health care provider. […] Some individuals are prone to breast tenderness, especially around the area where the abnormal cell growth is occurring. […] Atypical hyperplasia is typically identified through an irregular mammogram. It shows suspicious areas of dense tissue or calcification within the breast. […] In rare cases, women feel or even experience nipple discharge due to alteration in breast tissue caused by atypical hyperplasia. […] Early detection allows for better monitoring and reduces the risk of progression to breast cancer.

• #13 Best Breast Hyperplasia Treatment in Dubai

  https://kingscollegehospitaldubai.com/service/breast-health-clinic/hyperplasia-of-the-breast/

  Hyperplasia of the breast, also known as proliferative breast disease, is a non-cancerous breast condition that doesn’t present any obvious symptoms. The condition usually comes about due to an increase in the cells lining the breast lobules or ducts. […] Although atypical hyperplasia is non-cancerous, there are instances where it has been shown to increase the chances of developing cancer among some people. […] Since atypical lobular hyperplasia doesn’t show any symptoms, most females might be unaware of the condition until after a routine breast exam. That said, it is important to bring any breast symptoms you might have to the attention of your breast care specialist. These symptoms might include: Breast pain, Chest pain, Pain in the armpit, Uneven or misshapen breasts, Pain travelling from breast to armpit.

• #14 Atypical Hyperplasia of Breast | Symptoms, Causes & Treatment

  https://fitwellhub.pk/atypical-hyperplasia/

  Atypical hyperplasia may be symptomless. It occurs during regular breast imaging, but some people may feel they have this if the following symptoms are noted: […] In some cases, the condition may present as a palpable tumor in the breast. It may be identified during a self-exam or by a health care provider. […] Some individuals are prone to breast tenderness, especially around the area where the abnormal cell growth is occurring. […] Atypical hyperplasia is typically identified through an irregular mammogram. It shows suspicious areas of dense tissue or calcification within the breast. […] In rare cases, women feel or even experience nipple discharge due to alteration in breast tissue caused by atypical hyperplasia. […] Early detection allows for better monitoring and reduces the risk of progression to breast cancer.

• #15 Atypical cells in a breast lump | Other Conditions | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/breast-cancer/types/atypical-hyperplasia-breast-lump

  Atypical hyperplasia can increase your risk of developing breast cancer in the future. […] Atypical hyperplasia can sometimes develop as the breast changes with age. It can affect women of any age, but is more common in women over 35. […] Go to your doctor if you notice any new breast changes. You don’t need to wait for your clinic visit.

• #16 Atypical Ductal Hyperplasia: Breast Cancer Risk and More

  https://www.healthline.com/health/breast-cancer/atypical-ductal-hyperplasia

  A diagnosis of ADH doesnt mean that you have breast cancer. However, these unusual cells are more likely to turn into cancer. This means that you have a higher risk of developing breast cancer. […] According to the ACS, women with ADH or ALH are around four to five times more likely to develop breast cancer than women without breast abnormalities. However, the ACS also notes that most women with atypical hyperplasia dont develop breast cancer. […] Receiving an ADH diagnosis doesnt mean you have breast cancer, but it does increase your risk of developing it. Make sure you follow up with your doctor for regular screenings and tell them about any new symptoms you have. […] If you follow up with regular screenings, any signs of breast cancer will likely be caught before they start causing symptoms. Because breast cancer can affect each woman differently, its important to keep an eye out for certain warning signs. […] If you notice any of these warning signs, tell your doctor as soon as possible.

• #17 Atypical hyperplasia of the breast | Altru Health System

  https://www.altru.org/health-library/conditions/atypical-hyperplasia-of-the-breast

  Atypical hyperplasia of the breast usually doesn’t cause any symptoms. […] Atypical hyperplasia of the breast is typically found during a breast biopsy. […] If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia. […] Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time. At 25 years after diagnosis, about 30% of women with atypical hyperplasia may have breast cancer.

• #18 Hyperplasia and atypical hyperplasia | Breast Cancer Now

  https://breastcancernow.org/about-breast-cancer/breast-lumps-and-benign-not-cancer-breast-conditions/hyperplasia-and-atypical-hyperplasia

  Atypical hyperplasia (also called epithelial hyperplasia) happens when cells lining the ducts or lobules increase in number and develop an unusual pattern or shape. […] Atypical hyperplasia is also benign (not cancer). However, having atypical hyperplasia has been shown to increase the risk of breast cancer in some people. […] Hyperplasia and atypical hyperplasia do not usually cause any symptoms. Because of this, they’re usually found by chance when breast tissue that has been removed during a biopsy or breast surgery is examined under a microscope in the laboratory. […] If you have atypical hyperplasia, your risk of breast cancer is increased. Your treatment team will explain if and how you will be followed up. […] Go back to your GP if you notice any changes, no matter how soon they appear after your diagnosis of atypical hyperplasia.

• #19 Atypical hyperplasia of the breast – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia usually doesn’t cause any specific symptoms. […] Atypical hyperplasia is typically found during a breast biopsy to investigate an abnormality found on a mammogram or ultrasound. Sometimes atypical hyperplasia is discovered on a biopsy done to investigate a breast concern, such as a lump or nipple discharge. […] If you’ve been diagnosed with atypical hyperplasia, you have an increased risk of developing breast cancer in the future. For this reason, doctors often recommend intensive breast cancer screening and medications to reduce breast cancer risk. […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. The progression to breast cancer typically involves: Hyperplasia. The process begins when normal cell development and growth become disrupted, causing an overproduction of normal-looking cells (hyperplasia). Atypical hyperplasia. The excess cells stack upon one another and begin to take on an abnormal appearance. Noninvasive (in situ) cancer. The abnormal cells continue to progress in appearance and multiply, evolving into in situ cancer, in which cancer cells remain confined to milk ducts. Invasive cancer. The abnormal cells accumulate within the duct and continue to multiply and transition to become cancer cells. Invasive cancer tends to invade surrounding tissue, blood vessels or lymph channels.

• #20 Azthena logo with the word Azthena

  https://www.news-medical.net/health/Atypical-Hyperplasia.aspx

  Atypical hyperplasia is thus described as an accumulation of abnormally proliferating cells in the breast. It is not cancer, but can be a pre-cancerous condition, where the abnormal cells causing atypical hyperplasia keep dividing. This may result in non-invasive or invasive breast cancer in the long term. […] Women with a diagnosis of atypical hyperplasia have a higher risk of developing breast cancer in future, than those who do not have the condition. For this reason, intensive breast cancer screening and preventive medications to lower the risk of breast cancer is recommended in these cases. However, it is worth noting that the majority of women with atypical hyperplasia never develop breast cancer in their lifetime. […] Atypical hyperplasia does not cause any signs or symptoms in most cases, though breast changes may be detected on a mammogram.

• #21 Atypical hyperplasia of the breast – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia usually doesn’t cause any specific symptoms. […] Atypical hyperplasia is typically found during a breast biopsy to investigate an abnormality found on a mammogram or ultrasound. Sometimes atypical hyperplasia is discovered on a biopsy done to investigate a breast concern, such as a lump or nipple discharge. […] If you’ve been diagnosed with atypical hyperplasia, you have an increased risk of developing breast cancer in the future. For this reason, doctors often recommend intensive breast cancer screening and medications to reduce breast cancer risk. […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. The progression to breast cancer typically involves: Hyperplasia. The process begins when normal cell development and growth become disrupted, causing an overproduction of normal-looking cells (hyperplasia). Atypical hyperplasia. The excess cells stack upon one another and begin to take on an abnormal appearance. Noninvasive (in situ) cancer. The abnormal cells continue to progress in appearance and multiply, evolving into in situ cancer, in which cancer cells remain confined to milk ducts. Invasive cancer. The abnormal cells accumulate within the duct and continue to multiply and transition to become cancer cells. Invasive cancer tends to invade surrounding tissue, blood vessels or lymph channels.

• #22 Case: Atypical Ductal Hyperplasia – Radiology | UCLA Health

  https://www.uclahealth.org/departments/radiology/education/breast-imaging-teaching-resources/cases/atypical-ductal-hyperplasia

  Atypical ductal hyperplasia (ADH) is a non-malignant but high-risk lesion associated with progression to more advanced neoplasms including ductal carcinoma in situ (DCIS) and invasive carcinoma, and as a marker for the development of additional breast cancer. […] Atypical ductal hyperplasia is usually found incidentally on routine mammograms or breast MRI screenings. Although symptomatology and physical examination are vital to diagnosing breast pathology in general, ADH is usually too small to be appreciated upon palpation or to cause symptoms. […] Studies suggest surgical upgrade rates to DCIS or invasive carcinoma of up to 22-65% for biopsy-proven ADH. Thus, surgical excision is recommended for cases of ADH found on core needle biopsy. The prognosis usually depends on the final excisional biopsy results.

• #23 Atypical hyperplasia of the breast | Health Library | Memorial Health System

  https://www.mhsystem.org/health-library/con-20369759/

  Atypical hyperplasia of the breast is the development of precancerous cells in the breast. Atypical hyperplasia causes a buildup of cells in the breast tissue. When viewed with a microscope, the cells look different from typical breast cells. […] Atypical hyperplasia of the breast is typically found during a breast biopsy. A breast biopsy is a procedure to remove some breast cells for testing. […] Atypical hyperplasia of the breast usually doesn’t cause any symptoms. […] If you’ve been diagnosed with atypical hyperplasia of the breast, you have an increased risk of getting breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have atypical hyperplasia. The risk is similar for atypical ductal hyperplasia and atypical lobular hyperplasia.

• #24 Proliferative Breast Disease with Atypia | Dr. Garvit

  https://drgarvitchitkara.com/blogs/managing-proliferative-breast-disease-with-atypia/

  Atypical hyperplasia (or atypia) describes abnormal cell modifications that frequently point to precancerous or cancerous diseases. This is because of abnormal variations in cell size, shape, and organization. It calls for more research because of how important it is in pathological analyses, explains Dr. Garvit Chitkara, a breast cancer surgeon in Mumbai. […] Although atypical hyperplasia falls under the umbrella of benign breast conditions, it is considered a higher-risk category for cancer. The precise degree of the risk can vary depending on several factors, including the type of atypia, age, a family history of breast cancer, and other personal risk factors. […] Years of research have demonstrated that a woman’s later risk of developing breast cancer increases with her age at the time of her atypical hyperplasia diagnosis.

• #25 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  Atypical hyperplasia of the breast is defined as abnormal epithelial proliferative breast lesions that are not qualitatively or quantitatively abnormal enough to be classified as carcinoma in situ. Atypical hyperplasia is a premalignant condition and may occur in either ductal or lobular epithelium. […] Atypical ductal hyperplasia (ADH) is a relatively common lesion reported to be found in about 5% to 20% of breast biopsies. Although not carcinoma, it is classified as a high-risk precursor lesion due to its association with and potential to progress to ductal carcinoma in situ (DCIS) as well as invasive carcinoma. […] Atypical lobular hyperplasia (ALH), like ADH, is another high-risk breast lesion that has been associated with a four-fold to five-fold increased lifetime risk of developing breast cancer in either the ipsilateral or contralateral breast.

• #26 Understanding Your Pathology Report: Atypical Hyperplasia (Breast) | American Cancer Society

  https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/understanding-your-pathology-report/breast-pathology/atypical-hyperplasia.html

  Atypical hyperplasia means that there are more cells than usual, and they are no longer lined up in just the 2 layers. […] If the growth looks more abnormal, it may be called atypical hyperplasia. This can be either atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH). […] In ADH, the cells grow in an abnormal pattern and have some (but not all) of the features of ductal carcinoma in-situ (DCIS, which is a pre-cancer). This means that ADH is not yet a pre-cancer, although it is linked to an increased risk of getting breast cancer later on. […] Because having ADH increases your risk of breast cancer later on, your doctor may recommend more frequent follow up (with breast exams and imaging tests such as mammograms), as well as taking steps to lower your breast cancer risk, such as making lifestyle changes and taking medicine to help reduce your risk.

• #27 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  Atypical hyperplasia of the breast is defined as abnormal epithelial proliferative breast lesions that are not qualitatively or quantitatively abnormal enough to be classified as carcinoma in situ. Atypical hyperplasia is a premalignant condition and may occur in either ductal or lobular epithelium. […] Atypical ductal hyperplasia (ADH) is a relatively common lesion reported to be found in about 5% to 20% of breast biopsies. Although not carcinoma, it is classified as a high-risk precursor lesion due to its association with and potential to progress to ductal carcinoma in situ (DCIS) as well as invasive carcinoma. […] Atypical lobular hyperplasia (ALH), like ADH, is another high-risk breast lesion that has been associated with a four-fold to five-fold increased lifetime risk of developing breast cancer in either the ipsilateral or contralateral breast.

• #28 Understanding Your Pathology Report: Atypical Hyperplasia (Breast) | American Cancer Society

  https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/understanding-your-pathology-report/breast-pathology/atypical-hyperplasia.html

  ALH is an abnormal growth of cells within lobules of the breast that is linked with an increased risk of breast cancer. […] Because having ALH increases your risk of breast cancer later on, your doctor may recommend more frequent follow up (with breast exams and imaging tests such as mammograms), as well as taking steps to lower your breast cancer risk, such as making lifestyle changes and taking medicine to help reduce your risk.

• #29 Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape | Breast Cancer Research | Full Text

  https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0967-1

  ADH is not only a risk factor for IDC, it is also considered to be a direct but non-obligate precursor to carcinoma. […] Diagnosis of ADH carries a four- to fivefold increased risk of developing breast cancer within 5 years that is not limited to the ipsilateral breast. […] The occurrence of ADH in the general population varies widely from 3% of benign biopsies to 8-10% to 23%. […] The management of patients diagnosed with ADH on CNB varies not only because of the initial biopsy type/size but also because of the variable reported upgrade rate. […] Upgrade of ADH refers to the finding of cancer (DCIS/IDC) in the surgical excision biopsy that was not present in the CNB. […] One very recent review stated that 22-65% of ADH diagnosed by CNB were upgraded to carcinoma. […] Given the high upgrade rate, it is not surprising that the majority of clinicians suggest a surgical excision after ADH diagnosis on CNB to rule out concomitant malignancy.

• #30 Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a

  https://www.nature.com/articles/modpathol2017114

  A needle core biopsy diagnosis of atypical ductal hyperplasia is an indication for open biopsy. […] If the malignancies diagnosed after surgery for atypical ductal hyperplasia are dominated by low-risk ductal carcinoma in situ, women with atypical ductal hyperplasia may also be considered for surveillance. […] Overall 32 women, 29% of the whole cohort and 70% of those 46 with malignancy, required further surgery, including mastectomy in 12 (11%). […] However, 18% of women will have undiagnosed invasive breast cancer or non-low-risk ductal carcinoma in situ. […] A diagnosis of atypical ductal hyperplasia based on core biopsy findings of a screen-detected breast lesion represents one of the most common and least controversial indications for diagnostic open biopsy. […] The upgrade rate of atypical ductal hyperplasia in our series was 40%, well within the range of 956% reported in contemporary series.

• #31 Atypical hyperplasia of the breast – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia usually doesn’t cause any specific symptoms. […] Atypical hyperplasia is typically found during a breast biopsy to investigate an abnormality found on a mammogram or ultrasound. Sometimes atypical hyperplasia is discovered on a biopsy done to investigate a breast concern, such as a lump or nipple discharge. […] If you’ve been diagnosed with atypical hyperplasia, you have an increased risk of developing breast cancer in the future. For this reason, doctors often recommend intensive breast cancer screening and medications to reduce breast cancer risk. […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. The progression to breast cancer typically involves: Hyperplasia. The process begins when normal cell development and growth become disrupted, causing an overproduction of normal-looking cells (hyperplasia). Atypical hyperplasia. The excess cells stack upon one another and begin to take on an abnormal appearance. Noninvasive (in situ) cancer. The abnormal cells continue to progress in appearance and multiply, evolving into in situ cancer, in which cancer cells remain confined to milk ducts. Invasive cancer. The abnormal cells accumulate within the duct and continue to multiply and transition to become cancer cells. Invasive cancer tends to invade surrounding tissue, blood vessels or lymph channels.

• #32 Atypical hyperplasia of the breast – Vejthani Hospital | JCI Accredited International Hospital in Bangkok, Thailand.

  https://www.vejthani.com/diseases-conditions/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia is a precancerous condition affecting breast cells, characterized by the presence of abnormal cells in the milk ducts and lobules. While not cancer itself, atypical hyperplasia heightens the risk of developing breast cancer. If these abnormal cells continue to accumulate and become more irregular over time, there is a potential progression to noninvasive breast cancer (carcinoma in situ) or invasive breast cancer. […] Individuals diagnosed with atypical hyperplasia face an elevated risk of future breast cancer development. […] Typically, atypical hyperplasia does not manifest specific symptoms, making it challenging to identify without medical examination. […] Atypical hyperplasia is viewed as a component of the complex cellular transitions that could potentially lead to the onset of breast cancer. The progression to breast cancer typically involves the following stages:

• #33 Atypical hyperplasia of the breast – Augusta HealthSearchClose SearchSearch IconSearch IconClose Search IconMobile Menu IconMobile Menu Close IconInstagramFacebookTwitterYoutube

  https://www.augustahealth.com/disease/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia usually doesn’t cause any specific symptoms. […] Atypical hyperplasia is typically found during a breast biopsy to investigate an abnormality found on a mammogram or ultrasound. Sometimes atypical hyperplasia is discovered on a biopsy done to investigate a breast concern, such as a lump or nipple discharge. […] If you’ve been diagnosed with atypical hyperplasia, you have an increased risk of developing breast cancer in the future. For this reason, doctors often recommend intensive breast cancer screening and medications to reduce breast cancer risk. […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. The progression to breast cancer typically involves: Hyperplasia. The process begins when normal cell development and growth become disrupted, causing an overproduction of normal-looking cells (hyperplasia). Atypical hyperplasia. The excess cells stack upon one another and begin to take on an abnormal appearance. Noninvasive (in situ) cancer. The abnormal cells continue to progress in appearance and multiply, evolving into in situ cancer, in which cancer cells remain confined to milk ducts. Invasive cancer. The abnormal cells accumulate within the duct and continue to multiply and transition to become cancer cells. Invasive cancer tends to invade surrounding tissue, blood vessels or lymph channels.

• #34 Atypical hyperplasia of the breast – Vejthani Hospital | JCI Accredited International Hospital in Bangkok, Thailand.

  https://www.vejthani.com/diseases-conditions/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia: Excess cells accumulate and start to exhibit abnormal characteristics. […] Noninvasive (in situ) cancer: The abnormal cells continue to progress in appearance and multiply, evolving into in situ cancer. In this stage, cancer cells remain confined to the milk ducts. […] Invasive cancer: The abnormal cells further accumulate within the duct, continue to multiply, and transform into cancer cells. Invasive cancer is characterized by the invasion of surrounding tissues, blood vessels, or lymph channels.

• #35 Breast Pre-Cancer Conditions | Atypical Hyperplasia Treatment

  https://www.drnicoleyap.com.au/breast-pre-cancer-conditions/

  Atypical hyperplasia forms when breast cells become abnormal in number, size, shape, growth pattern and appearance. […] Atypical hyperplasia is thought to be part of the complex transition of cells that may accumulate and evolve into breast cancer. The progression to breast cancer typically involves: […] The excess cells stack upon one another and begin to take on an abnormal appearance. […] Once diagnosed with atypical hyperplasia, you have a risk factor that increases your risk of developing breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who do not have hyperplasia. […] The breast cancer risk with women with atypical hyperplasia increases over time: […] At 5 years after diagnosis, about 7% of women with atypical hyperplasia may develop breast cancer. […] At 10 years after diagnosis, about 13% of women with atypical hyperplasia may develop breast cancer. […] At 25 years after diagnosis, about 30% of women with atypical hyperplasia may develop breast cancer.

• #36 Atypical Hyperplasia – Tower Love Fund – Breast Cancer Explained

  https://www.towercancer.org/resource/breast-cancer-explained/atypical-hyperplasia/

  Atypical ductal hyperplasia (ADH) increases your risk of breast cancer occurring in the breast where the ADH was found. Atypical lobular hyperplasia (ALH) increases your risk of developing breast cancer in both breasts. Keep in mind, though, the vast majority of women diagnosed with ADH or ALH never go on to develop breast cancer. […] As pathologists have learned more about cells and how they change, it has become clear that what matters most is how far from normal a cell looks because the less normal the cell is in appearance, the greater the chance that genetic damage has occurred. And when genetic damage has occurred, a cell has the potential to become cancerous. This does not mean that a damaged cell will turn into a cancerous cell; it means it might. This drawing illustrates the potential progression from hyperplasia and/or atypia to invasive cancer.

• #37 Ductal or Lobular Hyperplasia | Medanta

  https://www.medanta.org/patient-education-blog/ductal-or-lobular-hyperplasia

  Breast cells can develop a precancerous condition called atypical hyperplasia. The term „atypical hyperplasia” refers to a build-up of aberrant cells in the breast’s milk ducts and lobules. […] Despite not being cancer, atypical hyperplasia raises the possibility of breast cancer. Atypical hyperplasia can develop into invasive or non-invasive breast cancer throughout your lifetime if abnormal cells build up in the milk lobules or ducts and grow more pronounced. […] Future breast cancer development is more likely to happen if you have been diagnosed with atypical hyperplasia. […] Typically, atypical hyperplasia does not manifest any particular symptoms. If you experience any signs or symptoms, schedule a visit with your doctor. […] Atypical hyperplasia is discovered when a breast biopsy is performed to look into an anomaly that was seen on mammography or ultrasound.

• #38 Atypical ductal hyperplasia – Wikipedia

  https://en.wikipedia.org/wiki/Atypical_ductal_hyperplasia

  Atypical ductal hyperplasia (ADH) is the term used for a benign lesion of the breast that indicates an increased risk of breast cancer. […] ADH, generally, is asymptomatic. It usually comes to medical attention on a screening mammogram, as a non-specific suspicious abnormality that requires a biopsy. […] The rate at which breast cancer (ductal carcinoma in situ or invasive mammary carcinoma) is found at the time of a surgical biopsy, following the diagnosis of ADH on a core biopsy varies considerably from hospital-to-hospital (range 4-54%). […] In two large studies, the conversion of an ADH on core biopsy to breast cancer on surgical excision, known as „up-grading”, is approximately 30%. […] The relative risk of breast cancer based on a median follow-up of 8 years, in a case control study of US registered nurses, is 3.7.

• #39 Atypical hyperplasia of the breast | Health Library | Memorial Health System

  https://www.mhsystem.org/health-library/con-20369759/

  Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time. At 25 years after diagnosis, about 30% of women with atypical hyperplasia may have breast cancer. Put another way, for every 100 women diagnosed with atypical hyperplasia, 30 can be expected to have breast cancer 25 years after diagnosis. And 70 will not develop breast cancer.

• #40 Atypical hyperplasia of the breast

  https://www.mymlc.com/health-information/diseases-and-conditions/a/atypical-hyperplasia-of-the-breast2/?section=Causes

  If you’ve been diagnosed with atypical hyperplasia, you have a risk factor that increases your risk of developing breast cancer in the future. The risk of breast cancer in those with atypical hyperplasia is about four times higher than in those who don’t have hyperplasia. […] Researchers who studied women with atypical hyperplasia found breast cancer risk increased over time: At 5 years after diagnosis, about 7% of women with atypical hyperplasia may develop breast cancer. […] At 10 years after diagnosis, about 13% of women with atypical hyperplasia may develop breast cancer. […] At 25 years after diagnosis, about 30% of women with atypical hyperplasia may develop breast cancer.

• #41 Atypical Ductal Hyperplasia: Breast, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/16242-atypical-ductal-hyperplasia

  The main complication of ADH is that it increases your risk for breast cancer. It’s important to follow your provider’s treatment plan, which typically involves annual mammograms or other breast cancer screenings. […] ADH itself isn’t cancer. It increases your risk for breast cancer in the future. A person with an atypical ductal hyperplasia diagnosis may not get breast cancer. Additionally, your breast cancer risk increases over time: After five years, about 7% of people with ADH will develop breast cancer. After 10 years, about 13% of people with ADH will develop breast cancer. After 25 years, about 30% of people with ADH will develop breast cancer. […] Your risk for breast cancer increases up to four times compared to someone without atypical hyperplasia. Other factors are involved in determining your overall risk. Be sure to discuss your risk with your healthcare provider. […] ADH increases your risk for breast cancer but doesn’t necessarily mean you’ll get breast cancer. Talk to your healthcare provider about your risk of developing cancer in the future. Be sure to ask any questions you have about treatment.

• #42 Atypical Hyperplasia

  https://cbcn.ca/en/atypical-hyperplasia

  Po 5 latach od zdiagnozowania atypowej hiperplazji 7% kobiet zostanie zdiagnozowanych z rakiem piersi; 10 lat po diagnozie atypowej hiperplazji 13% kobiet zostanie zdiagnozowanych z rakiem piersi; a 25 lat po diagnozie atypowej hiperplazji 30% kobiet rozwinie raka piersi. […] Nie ma zauważalnych oznak ani objawów atypowej hiperplazji; może wystąpić ból piersi, ale jest to bardzo rzadkie. Nie można jej również wykryć podczas badania piersi ani obrazowania piersi. […] Po zdiagnozowaniu atypowej hiperplazji może być wykonany test E-kadheryny, aby określić, czy masz ADH czy ALH.

• #43 Atypical hyperplasia of the breast | Health Library | Memorial Health System

  https://www.mhsystem.org/health-library/con-20369759/

  Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time. At 25 years after diagnosis, about 30% of women with atypical hyperplasia may have breast cancer. Put another way, for every 100 women diagnosed with atypical hyperplasia, 30 can be expected to have breast cancer 25 years after diagnosis. And 70 will not develop breast cancer.

• #44 Atypical hyperplasia of the breast – Hancock Health

  https://www.hancockhealth.org/mayo-health-library/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia of the breast usually doesnt cause any symptoms. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. […] Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time. At 25 years after diagnosis, about 30% of women with atypical hyperplasia may have breast cancer. Put another way, for every 100 women diagnosed with atypical hyperplasia, 30 can be expected to have breast cancer 25 years after diagnosis. […] Atypical hyperplasia of the breast increases the risk of breast cancer. So your healthcare team creates a breast cancer screening plan. You might have more-frequent screening or different screening tests than would someone with an average risk of breast cancer.

• #45 Navigating breast health: a comprehensive approach to atypical ductal hyperplasia of the breast management and surveillance

  https://www.explorationpub.com/Journals/em/Article/1001205

  Atypical ductal hyperplasia (ADH) is a benign lesion of the breast that is associated with an increased risk of invasive breast cancer. […] Atypical ductal hyperplasia (ADH) is one of the most common high-risk lesions of the breast and confers an increased lifetime risk of developing invasive breast cancer (IBC). […] The average latency period for progressing to invasive cancer is around 10 years. […] ADH is associated with a 3 to 5-fold increased relative risk for breast cancer, approximately 1% absolute risk per year for at least 25 years, and a 10-20% absolute lifetime risk of invasive carcinoma development. […] ADH is considered a high-risk breast lesion and there is an increase in both ipsilateral and bilateral breast cancer risk. […] The lifetime risk for women diagnosed with ADH, even after surgical excision is higher than average. […] Due to the high lifetime risk of breast cancer, all patients diagnosed with ADH should be offered lifelong clinical surveillance with clinical breast examination every 6-12 months, annual diagnostic MMO with tomography, and enhanced surveillance with annual MRI.

• #46 Atypical hyperplasia of the breast: Clinical cases and management strategies | Cleveland Clinic Journal of Medicine

  https://www.ccjm.org/content/90/7/423

  Atypical hyperplasia of the breast is a histopathologic lesion identified incidentally on image-guided breast biopsy. It is associated with a substantial increase in lifetime risk for breast cancer. For women with atypical hyperplasia, the cumulative breast cancer risk is approximately 1% per year. Atypical hyperplasia of the breast is a high-risk benign breast lesion that carries an increased lifetime risk for invasive breast cancer. The current recommendation is for an excisional biopsy for ADH identified on core needle biopsy, although there may be some cases wherein more than 90% of the lesion is removed by biopsy and no other high-risk features exist. Risk-reducing endocrine therapy should be discussed with patients because of increased lifetime risk of breast cancer, estimated at 1% per year. The absolute risk of developing breast cancer after a diagnosis of ALH is approximately 1% per year or approximately 30% at 25-year follow-up. The long-term risk of breast cancer for pure FEA is only mildly increased (relative risk, 2.0), a risk similar to that of proliferative breast disease without atypia. If the excisional biopsy does not show findings of ALH or ADH, risk-reducing endocrine therapy or surveillance with high-risk breast imaging is not required for pure FEA. However, if a validated risk assessment model suggests an increased risk of breast cancer based on family history, patients can be counseled about risk-reducing endocrine therapy. Untreated atypical endometrial hyperplasia can progress to endometrial cancer; therefore, hysterectomy is recommended. However, in patients with endometrial hyperplasia due to tamoxifen therapy who want to preserve fertility, tamoxifen should be discontinued.

• #47 Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape | Breast Cancer Research | Full Text

  https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-018-0967-1

  Unfortunately, risk prediction following ADH diagnosis is controversial, and counseling and further screening for these women diagnosed with ADH are therefore probably not adequate. […] Degnim et al. showed that the 25-year risk of developing cancer associated with ADH is at least 25%, and it could be as high as 50-60% if the ADH is both multifocal and calcified. […] Despite the high risk of developing cancer associated with ADH, attempts to identify clinicopathological or molecular biomarkers to predict individual risk have been unsuccessful.

• #48 Atypical Hyperplasia as a Predictor of Future Breast Cancer: Focus on Chemoprevention and Screening – The ASCO Post

  https://ascopost.com/issues/february-25-2015/atypical-hyperplasia-as-a-predictor-of-future-breast-cancer-focus-on-chemoprevention-and-screening.aspx

  Knowing the number of foci of atypical hyperplasia can further stratify the risk. We found that for women who had three or more foci of atypical hyperplasia, at 25 years, their risk was 47%, so almost 50%, or about a 2% risk per year, Dr. Degnim said. […] Although the majority of all women with atypical hyperplasia do not get breast cancer, the risk is quite high in some individuals. At 25 years, the risk of breast cancer for women with three or more foci of atypical hyperplasia was 47%.

• #49 Atypical Hyperplasia as a Predictor of Future Breast Cancer: Focus on Chemoprevention and Screening – The ASCO Post

  https://ascopost.com/issues/february-25-2015/atypical-hyperplasia-as-a-predictor-of-future-breast-cancer-focus-on-chemoprevention-and-screening.aspx

  Knowing the number of foci of atypical hyperplasia can further stratify the risk. We found that for women who had three or more foci of atypical hyperplasia, at 25 years, their risk was 47%, so almost 50%, or about a 2% risk per year, Dr. Degnim said. […] Although the majority of all women with atypical hyperplasia do not get breast cancer, the risk is quite high in some individuals. At 25 years, the risk of breast cancer for women with three or more foci of atypical hyperplasia was 47%.

• #50 Proliferative Breast Disease with Atypia | Dr. Garvit

  https://drgarvitchitkara.com/blogs/managing-proliferative-breast-disease-with-atypia/

  Atypical hyperplasia (or atypia) describes abnormal cell modifications that frequently point to precancerous or cancerous diseases. This is because of abnormal variations in cell size, shape, and organization. It calls for more research because of how important it is in pathological analyses, explains Dr. Garvit Chitkara, a breast cancer surgeon in Mumbai. […] Although atypical hyperplasia falls under the umbrella of benign breast conditions, it is considered a higher-risk category for cancer. The precise degree of the risk can vary depending on several factors, including the type of atypia, age, a family history of breast cancer, and other personal risk factors. […] Years of research have demonstrated that a woman’s later risk of developing breast cancer increases with her age at the time of her atypical hyperplasia diagnosis.

• #51 Pathology Outlines – Atypical ductal hyperplasia

  https://www.pathologyoutlines.com/topic/breastadh.html

  Intraductal clonal epithelial cell proliferation with similar histologic features to (but insufficient involvement or volume for the diagnosis of) low grade ductal carcinoma in situ (DCIS) […] Commonly presents in fourth decade […] 4 – 5x risk of developing ductal carcinoma in situ within 5 years (Cancer Prev Res (Phila) 2014;7:211) […] Absolute risk of breast cancer is approximately 1% per year for at least 25 years, with a mean latency period of 8 – 12 years after initial diagnosis […] Recent radiological pathological concordance series have shown that biopsy diagnosed atypical ductal hyperplasia (ADH) has an upgrade rate of 10 – 20% to DCIS or invasive carcinoma […] Higher risk with younger age, BRCA1 / BRCA2 mutations, family history, higher number of separate foci (overall volume), extent of lobular involution (complete / partial) correlated with age […] Most biopsy proven lesions undergo excision with some variation, as directed by imaging findings (e.g., small versus larger extent of calcifications) […] Tamoxifen reduced the risk of subsequent cancer from 21 to 7.5% (Breast Cancer Res 2018;20:39).

• #52

  https://link.springer.com/article/10.1007/s10549-017-4488-x

  Atypical ductal and atypical lobular hyperplasia (AH) of the breast are important proliferative lesions which are associated with a significantly increased risk for breast cancer. […] Atypical ductal and atypical lobular hyperplasia may be associated with the development of synchronous or metachronous breast cancer. Synchronous breast cancer occurs concomitantly with AH and is considered to represent local progression of AH. […] Women with AH are at significant risk for the development of metachronous breast cancer (MBC), and it is noteworthy that the characteristics of this event for AH are very similar to those of women with sporadic breast cancer for the development of contralateral breast cancer (CBC): (a) AH contains multiple advanced genomic changes including aneuploidy, gross chromosomal rearrangements, and DNA methylation of tumor suppressor genes, all of which are common in sporadic breast cancer.

• #53

  https://link.springer.com/article/10.1007/s10549-017-4488-x

  Atypical ductal and atypical lobular hyperplasia possess a wide range of advanced genomic changes including aneuploidy, loss of heterozygosity, gross chromosomal rearrangement such as amplifications and large-scale deletions, DNA methylation of tumor suppressor and other genes, and gene expression differences which are associated with a significant risk for breast cancer.

• #54 Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study – PubMed

  https://pubmed.ncbi.nlm.nih.gov/24480577/

  Atypical hyperplasia is a high-risk premalignant lesion of the breast, but its biology is poorly understood. […] For both ADH and ALH, there is a 2:1 ratio of ipsilateral to contralateral breast cancer. The ipsilateral predominance is marked in the first 5 years, consistent with a precursor phenotype for both ADH and ALH. […] Both ADH and ALH portend risk for ductal carcinoma in situ and invasive breast cancers, predominantly ductal, with two thirds moderate or high grade. The ipsilateral breast is at especially high risk for breast cancer in the first 5 years after atypia, with risk remaining elevated in both breasts long term. ADH and ALH behave similarly in terms of later breast cancer endpoints.

• #55 Atypical Hyperplasia – Tower Love Fund – Breast Cancer Explained

  https://www.towercancer.org/resource/breast-cancer-explained/atypical-hyperplasia/

  Atypical ductal hyperplasia (ADH) increases your risk of breast cancer occurring in the breast where the ADH was found. Atypical lobular hyperplasia (ALH) increases your risk of developing breast cancer in both breasts. Keep in mind, though, the vast majority of women diagnosed with ADH or ALH never go on to develop breast cancer. […] As pathologists have learned more about cells and how they change, it has become clear that what matters most is how far from normal a cell looks because the less normal the cell is in appearance, the greater the chance that genetic damage has occurred. And when genetic damage has occurred, a cell has the potential to become cancerous. This does not mean that a damaged cell will turn into a cancerous cell; it means it might. This drawing illustrates the potential progression from hyperplasia and/or atypia to invasive cancer.

• #56 Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study – PubMed

  https://pubmed.ncbi.nlm.nih.gov/24480577/

  Atypical hyperplasia is a high-risk premalignant lesion of the breast, but its biology is poorly understood. […] For both ADH and ALH, there is a 2:1 ratio of ipsilateral to contralateral breast cancer. The ipsilateral predominance is marked in the first 5 years, consistent with a precursor phenotype for both ADH and ALH. […] Both ADH and ALH portend risk for ductal carcinoma in situ and invasive breast cancers, predominantly ductal, with two thirds moderate or high grade. The ipsilateral breast is at especially high risk for breast cancer in the first 5 years after atypia, with risk remaining elevated in both breasts long term. ADH and ALH behave similarly in terms of later breast cancer endpoints.

• #57 Atypical Breast Hyperplasia – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK470258/

  When ADH or ALH is identified in a breast biopsy, the risk of developing DCIS or invasive breast cancer increases by four to five times with a 2:1 predilection for the ipsilateral breast versus contralateral. […] The lifetime risk of developing breast cancer in patients with ADH or ALH on biopsy is 15% to 20%. […] Atypical hyperplasia lesions are pre-malignant. Many authorities believe the patient should undergo complete surgical excision to exclude malignancy and prevent the development of advanced neoplasia if found on a breast biopsy. […] ADH is considered a pre-malignant, high-risk lesion, and ALH only a high-risk lesion. Either can be found in association with or at the periphery of a more advanced lesion; therefore, it is important to remember that atypical hyperplasia found on a biopsy may not accurately represent the greater lesion. […] It is important to note that while surgical excision after identifying atypical hyperplasia in a core biopsy is generally considered appropriate, some disagreement persists regarding the management of high-risk lesions in certain cases.

• #58 Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study – PubMed

  https://pubmed.ncbi.nlm.nih.gov/24480577/

  Atypical hyperplasia is a high-risk premalignant lesion of the breast, but its biology is poorly understood. […] For both ADH and ALH, there is a 2:1 ratio of ipsilateral to contralateral breast cancer. The ipsilateral predominance is marked in the first 5 years, consistent with a precursor phenotype for both ADH and ALH. […] Both ADH and ALH portend risk for ductal carcinoma in situ and invasive breast cancers, predominantly ductal, with two thirds moderate or high grade. The ipsilateral breast is at especially high risk for breast cancer in the first 5 years after atypia, with risk remaining elevated in both breasts long term. ADH and ALH behave similarly in terms of later breast cancer endpoints.

• #59 Atypical hyperplasia of the breast – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/atypical-hyperplasia/diagnosis-treatment/drc-20369778

  Atypical hyperplasia of the breast increases the risk of breast cancer. So your healthcare team creates a breast cancer screening plan. You might have more-frequent screening or different screening tests than would someone with an average risk of breast cancer. […] Treatment for atypical hyperplasia of the breast may involve surgery to remove the atypical cells. Not everyone needs surgery. Your healthcare team might recommend more-frequent breast cancer screening to watch for signs of breast cancer. […] If you have surgery, the tissue removed during the operation is tested in the lab to look for signs of cancer. Most people who have surgery for atypical hyperplasia don’t have breast cancer. But sometimes the surgery finds noninvasive breast cancer, also called ductal carcinoma in situ, or invasive breast cancer.

• #60 Atypical Lobular Hyperplasia and Risk of Breast Cancer

  https://www.verywellhealth.com/atypical-lobular-hyperplasia-of-the-breast-430684

  Atypical lobular hyperplasia doesn’t usually cause any symptoms, although it can cause non-specific breast pain in some people. Most people are unaware they have ALH until they get the results of a routine mammogram. […] Atypical lobular hyperplasia is a high-risk, precancerous lesion that can evolve into ductal carcinoma in situ (DCIS). […] Research suggests that the risk of developing breast cancer is as high as 20% if you have been diagnosed with ALH. That is significantly higher than the overall risk of breast cancer among females in the United States, which runs around 13%. […] ALH is a type of precancer in which abnormal cells develop in the milk-producing glands of the breast. ALH can lead to an early-stage cancer called ductal carcinoma in situ (DCIS) in up to one of every five people with ALH.

• #61 Atypical hyperplasia of the breast – Hancock Health

  https://www.hancockhealth.org/mayo-health-library/atypical-hyperplasia-of-the-breast/

  Atypical hyperplasia of the breast usually doesnt cause any symptoms. […] Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells are allowed to continue growing, they could get more DNA changes and become cancer cells. […] Studies of women with atypical hyperplasia have found that the risk of breast cancer increases over time. At 25 years after diagnosis, about 30% of women with atypical hyperplasia may have breast cancer. Put another way, for every 100 women diagnosed with atypical hyperplasia, 30 can be expected to have breast cancer 25 years after diagnosis. […] Atypical hyperplasia of the breast increases the risk of breast cancer. So your healthcare team creates a breast cancer screening plan. You might have more-frequent screening or different screening tests than would someone with an average risk of breast cancer.

• #62 Navigating breast health: a comprehensive approach to atypical ductal hyperplasia of the breast management and surveillance

  https://www.explorationpub.com/Journals/em/Article/1001205

  Atypical ductal hyperplasia (ADH) is a benign lesion of the breast that is associated with an increased risk of invasive breast cancer. […] Atypical ductal hyperplasia (ADH) is one of the most common high-risk lesions of the breast and confers an increased lifetime risk of developing invasive breast cancer (IBC). […] The average latency period for progressing to invasive cancer is around 10 years. […] ADH is associated with a 3 to 5-fold increased relative risk for breast cancer, approximately 1% absolute risk per year for at least 25 years, and a 10-20% absolute lifetime risk of invasive carcinoma development. […] ADH is considered a high-risk breast lesion and there is an increase in both ipsilateral and bilateral breast cancer risk. […] The lifetime risk for women diagnosed with ADH, even after surgical excision is higher than average. […] Due to the high lifetime risk of breast cancer, all patients diagnosed with ADH should be offered lifelong clinical surveillance with clinical breast examination every 6-12 months, annual diagnostic MMO with tomography, and enhanced surveillance with annual MRI.

• #63 Breast Cancer Risk: Usual and Atypical Hyperplasia | Susan G. Komen®

  https://www.komen.org/breast-cancer/risk-factor/hyperplasia-and-other-benign-breast-conditions/

  With atypical hyperplasia, the proliferating (dividing) cells look abnormal. […] Women with atypical hyperplasia have about 3 to 5 times the breast cancer risk of women without a proliferative breast condition. […] For women with atypical hyperplasia who also have a 20% or greater lifetime risk of invasive breast cancer, there are special breast cancer screening recommendations. […] The NCCN strongly recommends women with atypical hyperplasia take a risk-reducing drug (such as tamoxifen) to lower their risk of developing breast cancer. […] These drugs can lower the risk of breast cancer in women with atypical hyperplasia by about 86%.

• #64 Atypical Hyperplasia Treatment | New England Breast And Wellness

  https://www.nebreastandwellness.com/treatments/atypical-hyperplasia-treatment/

  Atypical hyperplasia can occur in the milky ducts (atypical ductal hyperplasia) or in the lobules (atypical lobular hyperplasia). Once atypical hyperplasia is diagnosed on a core biopsy, the doctor may recommend an excisional biopsy to examine the surrounding breast tissues. This ensures that atypical hyperplasia isnt symptomatic of a deeper problem or existing breast cancer. […] You’ll be placed on a close follow-up program for high-risk women if you’re diagnosed with atypical hyperplasia and have a family history of breast cancer. The follow-up program includes clinical breast exams once every six months and annual mammograms. Your doctor may also recommend various medications for breast cancer prevention (chemoprevention), such as tamoxifen and raloxifene.

• #65 Hyperplasia and atypical hyperplasia | Breast Cancer Now

  https://breastcancernow.org/about-breast-cancer/breast-lumps-and-benign-not-cancer-breast-conditions/hyperplasia-and-atypical-hyperplasia

  Atypical hyperplasia (also called epithelial hyperplasia) happens when cells lining the ducts or lobules increase in number and develop an unusual pattern or shape. […] Atypical hyperplasia is also benign (not cancer). However, having atypical hyperplasia has been shown to increase the risk of breast cancer in some people. […] Hyperplasia and atypical hyperplasia do not usually cause any symptoms. Because of this, they’re usually found by chance when breast tissue that has been removed during a biopsy or breast surgery is examined under a microscope in the laboratory. […] If you have atypical hyperplasia, your risk of breast cancer is increased. Your treatment team will explain if and how you will be followed up. […] Go back to your GP if you notice any changes, no matter how soon they appear after your diagnosis of atypical hyperplasia.

• #66

  https://www.kwongbreastclinic.com.sg/breast-health/benign-breast-conditions/atypical-hyperplasia/

  Atypical hyperplasia is an accumulation of abnormal cells in the breast and it is a risk factor for developing breast cancer. […] There is an increased risk of developing breast cancer in the future. It is about four times the lifetime risk. […] At 5 years after the diagnosis of atypical hyperplasia, 7 percent of the women may develop breast cancer. At 10 years after the diagnosis, 13 percent may develop breast cancer and at 25 years after the diagnosis, about 30 percent may develop breast cancer. […] Women with atypical hyperplasia should continue with monthly breast self-examinations in order to detect any early breast changes as well as consider annual mammograms, in view of the increased risk.

• #67 Breast Cancer Risk: Usual and Atypical Hyperplasia | Susan G. Komen®

  https://www.komen.org/breast-cancer/risk-factor/hyperplasia-and-other-benign-breast-conditions/

  With atypical hyperplasia, the proliferating (dividing) cells look abnormal. […] Women with atypical hyperplasia have about 3 to 5 times the breast cancer risk of women without a proliferative breast condition. […] For women with atypical hyperplasia who also have a 20% or greater lifetime risk of invasive breast cancer, there are special breast cancer screening recommendations. […] The NCCN strongly recommends women with atypical hyperplasia take a risk-reducing drug (such as tamoxifen) to lower their risk of developing breast cancer. […] These drugs can lower the risk of breast cancer in women with atypical hyperplasia by about 86%.

• #68 Atypical Hyperplasia of the Breast — Risk Assessment and Management Options – Breast360.org

  https://breast360.org/news/2015/09/15/atypical-hyperplasia-breast-risk-assessment-and-ma/

  Atypical hyperplasia is found in approximately 10% of all benign breast biopsies. […] Once a woman is diagnosed with atypical hyperplasia, she has a cumulative incidence of breast cancer (either ductal carcinoma in situ or invasive cancer) of 30% over the next 25 years, based on the Mayo Clinic Cohort study. […] The risk of breast cancer is higher in those diagnosed with atypical hyperplasia at a younger age and in those with a greater number of foci containing atypia. […] 97% of atypical ductal hyperplasia and 88% of atypical lobular hyperplasia has estrogen receptor staining, meaning it is stimulated by estrogen. […] A recent meta-analysis of selective estrogen receptor modulator trials found a 38% relative reduction in the risk of breast cancer in those taking the medication. […] Relative risk reductions in the atypical hyperplasia subgroup were even greater and ranged from 41% up to 79%.

• #69 Breast Hyperplasia: Is It Cancer? Can It Lead to Cancer?

  https://www.rockymountaincancercenters.com/blog/breast-hyperplasia-is-it-cancer-can-it-lead-to-cancer

  Hyperplasia doesn’t usually show specific symptoms. It’s most often discovered during a routine breast exam, mammogram, or ultrasound. If you develop symptoms a lump, area of thickness, or nipple discharge have it checked by your doctor. […] Breast hyperplasia is not cancer. However, it increases your risk of developing cancer in the future by four times more than a person without hyperplasia. […] You may be able to slow or stop the transition of atypical breast hyperplasia into estrogen-positive breast cancer by taking estrogen-blocking medication. Because estrogen boosts the growth of hormone-positive breast cancer, medications that block estrogen help lower your breast cancer risk. If taken for five years, they can provide up to 15 years of prevention.

• #70 Atypical Hyperplasia Treatment | New England Breast And Wellness

  https://www.nebreastandwellness.com/treatments/atypical-hyperplasia-treatment/

  Atypical hyperplasia can occur in the milky ducts (atypical ductal hyperplasia) or in the lobules (atypical lobular hyperplasia). Once atypical hyperplasia is diagnosed on a core biopsy, the doctor may recommend an excisional biopsy to examine the surrounding breast tissues. This ensures that atypical hyperplasia isnt symptomatic of a deeper problem or existing breast cancer. […] You’ll be placed on a close follow-up program for high-risk women if you’re diagnosed with atypical hyperplasia and have a family history of breast cancer. The follow-up program includes clinical breast exams once every six months and annual mammograms. Your doctor may also recommend various medications for breast cancer prevention (chemoprevention), such as tamoxifen and raloxifene.

• #71 Atypical Hyperplasia of the Breast — Risk Assessment and Management Options – Breast360.org

  https://breast360.org/news/2015/09/15/atypical-hyperplasia-breast-risk-assessment-and-ma/

  Atypical hyperplasia is found in approximately 10% of all benign breast biopsies. […] Once a woman is diagnosed with atypical hyperplasia, she has a cumulative incidence of breast cancer (either ductal carcinoma in situ or invasive cancer) of 30% over the next 25 years, based on the Mayo Clinic Cohort study. […] The risk of breast cancer is higher in those diagnosed with atypical hyperplasia at a younger age and in those with a greater number of foci containing atypia. […] 97% of atypical ductal hyperplasia and 88% of atypical lobular hyperplasia has estrogen receptor staining, meaning it is stimulated by estrogen. […] A recent meta-analysis of selective estrogen receptor modulator trials found a 38% relative reduction in the risk of breast cancer in those taking the medication. […] Relative risk reductions in the atypical hyperplasia subgroup were even greater and ranged from 41% up to 79%.

• #72 Menopausal symptom management considerations in patients at high risk for breast cancer – Women’s Healthcare

  https://www.npwomenshealthcare.com/menopausal-symptom-management-considerations-in-patients-at-high-risk-for-breast-cancer/

  Risk-reducing medications, also referred to as endocrine therapy (previously known as chemoprevention), are extremely effective in reducing breast cancer risk, especially for those with atypical hyperplasia and LCIS. Endocrine therapy has been shown to reduce breast cancer risk in patients with atypical hyperplasia by 86% and in those with LCIS by 50%.

• #73 Atypical Hyperplasia of the Breast — Risk Assessment and Management Options – Breast360.org

  https://breast360.org/news/2015/09/15/atypical-hyperplasia-breast-risk-assessment-and-ma/

  Atypical hyperplasia is found in approximately 10% of all benign breast biopsies. […] Once a woman is diagnosed with atypical hyperplasia, she has a cumulative incidence of breast cancer (either ductal carcinoma in situ or invasive cancer) of 30% over the next 25 years, based on the Mayo Clinic Cohort study. […] The risk of breast cancer is higher in those diagnosed with atypical hyperplasia at a younger age and in those with a greater number of foci containing atypia. […] 97% of atypical ductal hyperplasia and 88% of atypical lobular hyperplasia has estrogen receptor staining, meaning it is stimulated by estrogen. […] A recent meta-analysis of selective estrogen receptor modulator trials found a 38% relative reduction in the risk of breast cancer in those taking the medication. […] Relative risk reductions in the atypical hyperplasia subgroup were even greater and ranged from 41% up to 79%.

• #74 Atypical Hyperplasia of the Breast — Risk Assessment and Management Options – Breast360.org

  https://breast360.org/news/2015/09/15/atypical-hyperplasia-breast-risk-assessment-and-ma/

  Despite the evidence that chemoprevention medications work, patients are reluctant to take them due to fear of side effects. […] The serious risks associated with tamoxifen and raloxifene are related to thromboembolic events, including deep venous thromboses and pulmonary emboli, and are infrequent. […] The risk of venous thromboembolisms with these medications ranges from 5.9 to 14 per 1000 women. […] Tamoxifen (but not raloxifene or the aromatase inhibitors) is also associated with an increased incidence of endometrial cancer of 5.5 per 1000 women, mainly in those who are postmenopausal.

Zobacz więcej